Patient Guide: Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • āœ“ Get matched to the right study location for you
  • āœ“ Connect directly with study coordinators at 7 participating sites
  • āœ“ Understand eligibility with our simplified screening tool
  • āœ“ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06250036
Status: 🟢 Enrolling Now
Condition: Adenocarcinoma, Stomach Neoplasms
Phase: PHASE2

Find a Study Location Near You

This study is available at 7 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Cambridge, Cambridgeshire
  • • Exeter, Devon
  • • Canterbury, Kent
  • • And 4 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily